Rigel Pharmaceuticals, Inc. (RIGL)

42.48 +1.70 (+4.17%) USD  |  NASDAQ  |  Dec 15, 16:00
42.78 +0.30 (+0.71%) After-Hours: 20:00
More

Rigel Pharmaceuticals Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Vertex Pharmaceuticals, Inc. Upgrade